BabyBIG

botulism immune globulin intravenous

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BabyBIG, covering 2021-10-19 to 2026-06-18. Get the full timeline:

Most recent: Clinical Trial Results: Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG® [Phase 2]